Immunomodulatory effects of antipsychotic treatment on gene expression in first-episode psychosis
Outi Mantere(Douglas Mental Health University Institute), Jaana Suvisaari, Kalevi Trontti(University of Helsinki), Ingrid Balcells(University of Helsinki), Judit García‐González(Icahn School of Medicine at Mount Sinai), Suvi Saarnio(University of Helsinki), Jarno Honkanen(University of Helsinki), Teemu Mäntylä(University of Helsinki), Iiris Hovatta(University of Helsinki), Tuukka T. Raij(Helsinki University Hospital), Outi Vaarala(Orion Corporation (United Kingdom)), Maija Lindgren(Finnish Institute for Health and Welfare), Tuula Kieseppä(Hospital District of Helsinki and Uusimaa)
Cited by 33
Related Papers
Large recurrent microdeletions associated with schizophrenia
|Nature|2008|1.8k
Common variants conferring risk of schizophrenia
|Nature|2009|1.7k
The Dynamics of the Human Infant Gut Microbiome in Development and in Progression toward Type 1 Diabetes
|Cell Host & Microbe|2015|1.2k
Genome Scan Meta-Analysis of Schizophrenia and Bipolar Disorder, Part II: Schizophrenia
|The American Journal of Human Genetics|2003|1.1k
The “Perfect Storm” for Type 1 Diabetes
|Diabetes|2008|495